Viewing StudyNCT00433927



Ignite Creation Date: 2024-05-05 @ 5:22 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00433927
Status: UNKNOWN
Last Update Posted: 2014-03-14
First Post: 2007-02-09

Brief Title: 5-FU Folinic Acid and Irinotecan FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer CRC
Sponsor: PD Dr med Volker Heinemann
Organization: Ludwig-Maximilians - University of Munich

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-01
Start Date Type: None
Primary Completion Date: 2014-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2016-12
Completion Date Type: ESTIMATED
First Submit Date: 2007-02-09
First Submit QC Date: February 9 2007
Study First Post Date: 2007-02-12
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-03-13
Last Update Post Date: 2014-03-14
Last Update Post Date Type: ESTIMATED